Carcinoid & Neuroendocrine Tumor Society

An association of patients, caregivers and physicians, promoting better understanding of carcinoid and neuroendocrine cancer,
a relatively rare disease which is poorly understood and is often misdiagnosed.

Home  |  About Us  |  Events  |  Resources  |  Fees & Benefits  |  Registration  |  Contacts
Past Event - 3 April 09
CNETS organised a free seminar, its second public event, held in Singapore at the National Cancer Centre Theatre on 3 April 2009.

"The Evolution of Diagnostic and Treatment Options for Carcinoid and Neuroendocrine Patients"

Presented by Professor Dr. Larry K. Kvols

In his landmark article for the first issue of the Journal of Clinical Oncology in 1983, Dr. C.G. Moertel concluded:

"The patient with carcinoid tumor should not be a fascinating curio for grand rounds exhibition. He should be a focal point for research involving an experienced, multidisciplinary clinical team supported by devoted basic scientists. If our patient resources and efforts can be concentrated in this manner, the carcinoid should be a strong candidate for the next medically curable cancer."

Dr. Kvols is an expert in carcinoid disease who worked with Dr. Moertel for many years at the Mayo Clinic, and recently authored a retrospective article examining Moertel's remarkable insights for the 25th anniversary issue of JCO. In his talk to our audience in Singapore, Dr. Kvols shared with us how the diagnosis and treatment of neuroendocrine tumors has evolved in the past 25 years.

Dr. Larry Kvols Larry K. Kvols is a Professor of Interdisciplinary Oncology and Head of the Neuroendocrinology Section at the Moffitt Cancer Center in Tampa Florida. Prior to joining Moffitt, Dr. Kvols was CEO and Director of the University of New Mexico Cancer Research and Treatment Center. He is a graduate of Baylor College of Medicine, completing his residency, internship and fellowship at Johns Hopkins Hospital. He was Professor of Oncology at the Mayo Medical School and the Mayo Clinic. His research interests are focused on the diagnosis and treatment of neuroendocrine tumors, for which he is world-renowned.

The talk was introduced by William Claxton, co-founder of CNETS Singapore, and Dr. Liau Kui Hin, Consultant Surgeon and Chief of Hepatobiliary and Pancreatic Surgery at Tan Tock Seng Hospital, Singapore.

As part of our outreach to patients, caregivers and physicians throughout the region, we are webcasting the presentation by Dr. Kvols. Actually, this webcast was transmitted live over the Internet, and announced via the ACOR forum.

This was the first live transmission of a seminar on carcinoid and neuroendocrine tumors, and to achieve it we used a new software tool known as 'Wirecast' which allows us to switch between video and slides while transmitting and recording the webcast. We also used a software known as 'Cursor Attention' to make the cursor easily visible both to attendees in the room and viewers on the Internet.

Unfortunately, there was a technical issue that required us to switch machines just prior to the transmission. The backup PC we used was underpowered and dropped frames resulting in choppy audio. Also, during the first 2 minutes of the video the audio levels were too low. We hope you will excuse these technical faults, and enjoy the webcast nonetheless.
   View the webcast:
Video & Slides  |  Opening Remarks (pdf)
Duration: 1 hour 13 minutes
(Windows Media broadband)
CNETS logo
Supporting organisations

This event was supported by National Cancer Center of Singapore, the Chapter of Gastroenterologists College of Physicians, and Novartis Oncology.